These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1298 related articles for article (PubMed ID: 17967063)
1. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063 [TBL] [Abstract][Full Text] [Related]
2. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Han H; Cortez CC; Yang X; Nichols PW; Jones PA; Liang G Hum Mol Genet; 2011 Nov; 20(22):4299-310. PubMed ID: 21835883 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405 [TBL] [Abstract][Full Text] [Related]
4. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. Stimson KM; Vertino PM J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524 [TBL] [Abstract][Full Text] [Related]
5. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. Newell-Price J; King P; Clark AJ Mol Endocrinol; 2001 Feb; 15(2):338-48. PubMed ID: 11158338 [TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
7. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. Xu J; Huo D; Chen Y; Nwachukwu C; Collins C; Rowell J; Slamon DJ; Olopade OI Breast Cancer Res Treat; 2010 Apr; 120(3):593-601. PubMed ID: 19466541 [TBL] [Abstract][Full Text] [Related]
8. Predicting aberrant CpG island methylation. Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation determines nucleosome occupancy in the 5'-CpG islands of tumor suppressor genes. Portela A; Liz J; Nogales V; Setién F; Villanueva A; Esteller M Oncogene; 2013 Nov; 32(47):5421-8. PubMed ID: 23686312 [TBL] [Abstract][Full Text] [Related]
10. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960 [TBL] [Abstract][Full Text] [Related]
11. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Bell A; Bell D; Weber RS; El-Naggar AK Cancer; 2011 Jul; 117(13):2898-909. PubMed ID: 21692051 [TBL] [Abstract][Full Text] [Related]
12. CpG island methylation status in the EpCAM promoter region and gene expression. Yu G; Zhang X; Wang H; Rui D; Yin A; Qiu G; He Y Oncol Rep; 2008 Nov; 20(5):1061-7. PubMed ID: 18949402 [TBL] [Abstract][Full Text] [Related]
13. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
14. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. Saied MH; Marzec J; Khalid S; Smith P; Down TA; Rakyan VK; Molloy G; Raghavan M; Debernardi S; Young BD PLoS One; 2012; 7(3):e33213. PubMed ID: 22479372 [TBL] [Abstract][Full Text] [Related]
15. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma. Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234 [TBL] [Abstract][Full Text] [Related]
17. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation. Lim JH; Kim SP; Gabrielson E; Park YB; Park JW; Kwon TK Int J Cancer; 2005 Aug; 116(2):200-6. PubMed ID: 15800911 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185 [TBL] [Abstract][Full Text] [Related]
19. Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues. Velasco G; Hubé F; Rollin J; Neuillet D; Philippe C; Bouzinba-Segard H; Galvani A; Viegas-Péquignot E; Francastel C Proc Natl Acad Sci U S A; 2010 May; 107(20):9281-6. PubMed ID: 20439742 [TBL] [Abstract][Full Text] [Related]
20. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]